Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ulmus minor response to Dutch elm disease: de novo transcriptome assembly and annotation.

Scientific data·2025
Same author

Cyclic mechanical loading of photopolymerized methacrylated hydrogels for probing interdependent effects of strain, stiffness, and substrate composition in pulmonary fibrogenesis.

Scientific reports·2025
Same author

Magnetite nanoparticles as a kinetically favorable source of iron to enhance GBM response to chemoradiosensitization with pharmacological ascorbate.

Redox biology·2023
Same author

Coal Tar Antipyretics.

Atlanta medical and surgical journal (1884)·2022
Same author

No priming, just fighting-endophytic yeast attenuates the defense response and the stress induced by Dutch elm disease in Ulmus minor Mill.

Tree physiology·2022
Same author

Mouse Keratinocytes Without Keratin Intermediate Filaments Demonstrate Substrate Stiffness Dependent Behaviors.

Cellular and molecular bioengineering·2019
Same journal

Enzymatically Crosslinked Hybrid Hydrogels from Ultrasound-Decellularized Spinal Cord Meninges and Hydrophilic Silk Fibroin for Neural Tissue Engineering.

ACS biomaterials science & engineering·2026
Same journal

Biomimetic Piezoelectric Nanoparticles for Targeted Ultrasound-Driven Neuromodulation and Precise Neurotransmitter Release.

ACS biomaterials science & engineering·2026
Same journal

Nitrogen Plasma-Modified Silk Fibroin Films Promote Wettability and Airway Epithelial Cell Growth.

ACS biomaterials science & engineering·2026
Same journal

Cell-Friendly 3D Bioprinting of Gelatin-Norbornene Bioink via Thiol-Ene Crosslinking Enabled by Interfacial DTT Delivery from Alternating Support Layers.

ACS biomaterials science & engineering·2026
Same journal

Hemocompatibility of 3D-Printed ABS for Blood-Contacting Applications.

ACS biomaterials science & engineering·2026
Same journal

DNA Origami Microstructures as Biomimetic Scaffolds for Calcium Phosphate Mineralization.

ACS biomaterials science & engineering·2026
See all related articles

Related Experiment Video

Updated: Nov 21, 2025

Author Spotlight: Exploring the Potential of Fat-Derived Stromal Vascular Fraction for Wound Healing
05:30

Author Spotlight: Exploring the Potential of Fat-Derived Stromal Vascular Fraction for Wound Healing

Published on: November 17, 2023

896

Blebbistatin-Loaded Poly(d,l-lactide-co-glycolide) Particles For Treating Arthrofibrosis.

K Atluri1, A M De Jesus2, S Chinnathambi2

  • 1Division of Pharmaceutics and Translational Therapeutics, University of Iowa College of Pharmacy, 115 South Grand Avenue, Iowa City, Iowa 52242, United States.

ACS Biomaterials Science & Engineering
|January 15, 2021
PubMed
Summary
This summary is machine-generated.

Bleeding-edge research shows that blebbistatin, a nonmuscle myosin II inhibitor, effectively reduces fibroblast-mediated fibrosis and collagen production. This drug, delivered via poly(lactide-co-gylcolide) particles, offers a promising new treatment for joint immobility.

Keywords:
Rho/ROCK pathwayactincollagenfibroblastsfibrosishydroxyprolinejoint capsulemechanical stimulationmyosintraction forces

More Related Videos

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.8K
Postproduction Processing of Electrospun Fibres for Tissue Engineering
15:52

Postproduction Processing of Electrospun Fibres for Tissue Engineering

Published on: August 9, 2012

18.5K

Related Experiment Videos

Last Updated: Nov 21, 2025

Author Spotlight: Exploring the Potential of Fat-Derived Stromal Vascular Fraction for Wound Healing
05:30

Author Spotlight: Exploring the Potential of Fat-Derived Stromal Vascular Fraction for Wound Healing

Published on: November 17, 2023

896
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
12:27

Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery

Published on: August 22, 2016

7.8K
Postproduction Processing of Electrospun Fibres for Tissue Engineering
15:52

Postproduction Processing of Electrospun Fibres for Tissue Engineering

Published on: August 9, 2012

18.5K

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Drug Delivery

Background:

  • Joint immobility, a complication of articular trauma, involves joint capsule stiffening and intra-articular fibrosis.
  • Fibroblasts exert tension on the extracellular matrix (ECM) via nonmuscle myosin II, contributing to scar contraction and recurrence of immobility.
  • Current surgical interventions offer temporary relief, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the efficacy of blebbistatin, a nonmuscle myosin II inhibitor, in reducing fibroblast-mediated ECM tension and fibrosis.
  • To compare the anti-fibrotic effects of sustained drug delivery using blebbistatin-loaded poly(lactide-co-gylcolide) (PLGA) particles versus bolus blebbistatin administration.
  • To establish a foundation for optimizing drug delivery technologies for treating arthrofibrosis.

Main Methods:

  • Utilized time-lapse imaging of fluorescent microspheres embedded in collagen gels to quantify fibroblast-mediated ECM displacement.
  • Administered blebbistatin via PLGA nanoparticles and compared outcomes to bolus blebbistatin dosing.
  • Assessed collagen production at 10 days post-treatment.

Main Results:

  • PLGA/blebbistatin particles significantly inhibited fibroblast force generation, reducing both the extent and rate of collagen gel displacement.
  • Sustained delivery via PLGA particles demonstrated effectiveness in suppressing contractile activity.
  • Collagen production was significantly reduced at 10 days, indicating a decrease in fibrotic processes.

Conclusions:

  • Blebbistatin effectively inhibits fibroblast force generation, thereby reducing ECM tension and collagen production.
  • Blebbistatin-loaded PLGA particles provide a viable strategy for sustained drug delivery to combat arthrofibrosis.
  • These findings support the development of targeted drug delivery systems for managing joint fibrosis and immobility.